Considering that Pirfenidone is metabolised in the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is likely to precipitate the toxicity of pirfenidone: concomitant therapy will be to be prevented. In May perhaps 2014, the outcome of A further randomized, double-blind, placebo-managed trial that enrolled 555 clients have been https://brucek766zju9.wikifrontier.com/user